Literature DB >> 15588946

Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use.

Norbert Stute1, Katja Holtz, Michael Bubenheim, Claudia Lange, Felix Blake, Axel R Zander.   

Abstract

OBJECTIVE: Mesenchymal stem cells (MSC) are promising candidates for cell-based therapies. One major obstacle for their clinical use is the biosafety of fetal calf serum (FCS), which is a crucial part of all media currently used for the culture of MSC.
METHODS: Nine donors each contributed 5 mL of bone marrow aspirate. Isolation of MSC was conducted according to Caplan et al., although for expansion we used low-density seeding with 20 MSC/cm2. Four different media A, B, C, and D were tested, containing 1%, 3%, or 10% autologous serum (AS), or 10% selected FCS, respectively. MSC were cultured on 24-well plates until passage 2 and counted under the microscope at regular intervals. Osteogenic and adipogenic differentiation were induced in vitro by using a modified standard cocktail and were evaluated semi-quantitatively through a microscope.
RESULTS: Isolation of MSC after 3 days appeared best in media C with almost always C>D congruent with B>A. Proliferation was exponential with generally C>D>B>A. Morphologically, MSC isolated and expanded in medium C were indistinguishable from those in medium D. Phenotypic markers of MSC grown in medium C were: CD34-, CD45-, CD90+, CD105+, MHC class I+, MHC class II-, similar to MSC isolated and grown in medium D. Moreover, MSC grown in medium C showed more osteogenic potential than those from medium D in all cases: C+++, D++, B+, A 0. Cells retained their immaturity as shown by adipogenic differentiation and it always was: D+++, C++, B+, A 0.
CONCLUSIONS: Growth of MSC in a FCS-free medium is feasible without addition of growth factors. Ten percent AS appears at least as good as 10% FCS with regard to both isolation and expansion of human MSC, while 1% and 3% AS appear inferior. With respect to osteogenic differentiation, 10% AS proved superior to the other serum conditions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15588946     DOI: 10.1016/j.exphem.2004.09.003

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  66 in total

Review 1.  Mesenchymal stromal cells for cell therapy: besides supporting hematopoiesis.

Authors:  Lei Hao; Huiqin Sun; Jin Wang; Tao Wang; Mingke Wang; Zhongmin Zou
Journal:  Int J Hematol       Date:  2011-12-20       Impact factor: 2.490

2.  Xeno-free proliferation of human bone marrow mesenchymal stem cells.

Authors:  Hiroto Miwa; Yoshiki Hashimoto; Keiji Tensho; Shigeyuki Wakitani; Mutsumi Takagi
Journal:  Cytotechnology       Date:  2011-10-15       Impact factor: 2.058

Review 3.  The potential of adipose stem cells in regenerative medicine.

Authors:  Bettina Lindroos; Riitta Suuronen; Susanna Miettinen
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

Review 4.  Mesenchymal stem cell preparations--comparing apples and oranges.

Authors:  Wolfgang Wagner; Anthony D Ho
Journal:  Stem Cell Rev       Date:  2007-12       Impact factor: 5.739

5.  Validity of bone marrow stromal cell expansion by animal serum-free medium for cell transplantation therapy of cerebral infarct in rats-a serial MRI study.

Authors:  Masaki Ito; Satoshi Kuroda; Taku Sugiyama; Hideo Shichinohe; Yukari Takeda; Mitsufumi Nishio; Takao Koike; Kiyohiro Houkin
Journal:  Transl Stroke Res       Date:  2011-07-26       Impact factor: 6.829

Review 6.  Current status of cell therapies in stroke.

Authors:  Oh Young Bang
Journal:  Int J Stem Cells       Date:  2009-05       Impact factor: 2.500

7.  Clinical grade adult stem cell banking.

Authors:  Sreedhar Thirumala; W Scott Goebel; Erik J Woods
Journal:  Organogenesis       Date:  2009-07       Impact factor: 2.500

8.  Phenotypic Characterization of Mesenchymal Stem Cells from Various Tissues.

Authors:  Markus Thomas Rojewski; Barbara Maria Weber; Hubert Schrezenmeier
Journal:  Transfus Med Hemother       Date:  2008-05-16       Impact factor: 3.747

9.  Differential gene expression in adipose stem cells cultured in allogeneic human serum versus fetal bovine serum.

Authors:  Bettina Lindroos; Kaisa-Leena Aho; Hannu Kuokkanen; Sari Räty; Heini Huhtala; Riina Lemponen; Olli Yli-Harja; Riitta Suuronen; Susanna Miettinen
Journal:  Tissue Eng Part A       Date:  2010-07       Impact factor: 3.845

10.  Optimization of culture condition of human bone marrow stromal cells in terms of purification, proliferation, and pluripotency.

Authors:  Ying Zhou; Dan Yu; Huiyong Zhu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-06-17       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.